Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02287701 · ClinicalTrials.gov registry record · NA
Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT02287701 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 24 participants.
The verdict
NCT02287701, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade, stage, and treatment response.
Interventions
- PROCEDURE PET/MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02287701
The ClinicalTrials.gov registry entry for NCT02287701 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PET/MRI is the first listed.
NCT02287701 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02287701 about?
NCT02287701 is a clinical study titled "Exploratory Investigation of Advanced PET/MRI Metrics for Bladder Cancer Characterization". The overarching goal of this project is to explore whether associations exist between metrics obtained from PET/MRI incorporating advanced MRI sequences and features of bladder cancer, including grade, stage, and treatment response.
What is the current status of trial NCT02287701?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2014-05. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02287701?
The interventions under investigation include: PET/MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02287701?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.